Talis Announces Fourth Quarter and Full Year 2022 Financial Results
22 mars 2023 16h05 HE
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of...
Talis Biomedical Reports Third Quarter 2022 Financial Results
03 nov. 2022 16h05 HE
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of...
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results
02 août 2022 16h05 HE
|
Talis Biomedical Corporation
REDWOOD CITY, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces First Quarter 2022 Financial Results
10 mai 2022 16h05 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022
26 avr. 2022 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious...
Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
15 mars 2022 16h05 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022
01 mars 2022 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes through the delivery of accurate infectious...
Talis Biomedical Announces Leadership Transition
08 déc. 2021 08h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 déc. 2021 17h00 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...
Talis Biomedical Announces Third Quarter 2021 Financial Results and Business Progress
15 nov. 2021 16h05 HE
|
Talis Biomedical Corporation
MENLO PARK, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to advancing health equity and outcomes through the delivery of accurate...